Inhaltsangabe
In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Über die Autorin bzw. den Autor
Dr. Neelam Redhu has been working on study of microbiology of pathogenic strains and their inhibitor designing and developed several good inhibitors in laboratory. Dr. Anurag Khatkar has been working in Department of Pharmaceutical Sciences, M.D.University, Rohtak and he has published many good papers in high impact journals.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Suchergebnisse für In-Silico Approach for Alpha-Glycosidase and Urease...
Foto des Verkäufers
In-Silico Approach for Alpha-Glycosidase and Urease Inhibitor Search
Verlag:
LAP LAMBERT Academic Publishing Okt 2021, 2021
ISBN 10: 620420985X
ISBN 13: 9786204209852
Neu
Taschenbuch
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively. 168 pp. Englisch. Bestandsnummer des Verkäufers 9786204209852
Neu kaufen
EUR 71,90
EUR 23,00 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 2 verfügbar
Foto des Verkäufers
In-Silico Approach for Alpha-Glycosidase and Urease Inhibitor Search
Verlag:
LAP LAMBERT Academic Publishing, 2021
ISBN 10: 620420985X
ISBN 13: 9786204209852
Neu
Softcover
Anbieter: moluna, Greven, Deutschland
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. Bestandsnummer des Verkäufers 526153380
Neu kaufen
EUR 58,12
EUR 48,99 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
In-Silico Approach for Alpha-Glycosidase and Urease Inhibitor Search
Verlag:
LAP LAMBERT Academic Publishing Okt 2021, 2021
ISBN 10: 620420985X
ISBN 13: 9786204209852
Neu
Taschenbuch
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 168 pp. Englisch. Bestandsnummer des Verkäufers 9786204209852
Neu kaufen
EUR 71,90
EUR 60,00 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 1 verfügbar
Foto des Verkäufers
In-Silico Approach for Alpha-Glycosidase and Urease Inhibitor Search
Verlag:
LAP LAMBERT Academic Publishing, 2021
ISBN 10: 620420985X
ISBN 13: 9786204209852
Neu
Taschenbuch
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively. Bestandsnummer des Verkäufers 9786204209852
Neu kaufen
EUR 72,76
EUR 61,34 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 1 verfügbar